Rhenman & Partners Asset Management AB as of June 30, 2014
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 96 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 4.7 | $16M | 50k | 315.32 | |
| Covidien | 4.6 | $15M | 171k | 90.18 | |
| Gilead Sciences (GILD) | 4.4 | $15M | 180k | 82.91 | |
| Alexion Pharmaceuticals | 4.3 | $15M | 93k | 156.25 | |
| Celgene Corporation | 4.0 | $14M | 157k | 85.88 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.9 | $9.6M | 102k | 94.68 | |
| BioMarin Pharmaceutical (BMRN) | 2.8 | $9.3M | 150k | 62.21 | |
| Alkermes (ALKS) | 2.5 | $8.5M | 168k | 50.33 | |
| Incyte Corporation (INCY) | 2.2 | $7.5M | 133k | 56.44 | |
| Cardinal Health (CAH) | 2.0 | $6.8M | 99k | 68.56 | |
| Allergan | 2.0 | $6.8M | 40k | 169.22 | |
| Regeneron Pharmaceuticals (REGN) | 1.9 | $6.4M | 23k | 282.49 | |
| Actavis | 1.6 | $5.6M | 25k | 223.04 | |
| Salix Pharmaceuticals | 1.6 | $5.4M | 44k | 123.35 | |
| Boston Scientific Corporation (BSX) | 1.6 | $5.3M | 415k | 12.77 | |
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $5.2M | 230k | 22.59 | |
| CIGNA Corporation | 1.5 | $5.1M | 55k | 91.96 | |
| Pharmacyclics | 1.5 | $4.9M | 55k | 89.71 | |
| Community Health Systems (CYH) | 1.4 | $4.6M | 102k | 45.37 | |
| Cyberonics | 1.4 | $4.6M | 74k | 62.46 | |
| Merck & Co (MRK) | 1.3 | $4.5M | 78k | 57.85 | |
| Bristol Myers Squibb (BMY) | 1.2 | $4.1M | 85k | 48.51 | |
| McKesson Corporation (MCK) | 1.2 | $4.0M | 22k | 186.23 | |
| Medivation | 1.2 | $4.0M | 52k | 77.08 | |
| Dex (DXCM) | 1.2 | $4.0M | 100k | 39.66 | |
| Insulet Corporation (PODD) | 1.2 | $4.0M | 100k | 39.67 | |
| Thermo Fisher Scientific (TMO) | 1.2 | $3.9M | 33k | 118.00 | |
| CVS Caremark Corporation (CVS) | 1.1 | $3.8M | 50k | 75.38 | |
| Clovis Oncology | 1.1 | $3.7M | 90k | 41.41 | |
| Keryx Biopharmaceuticals | 1.1 | $3.7M | 240k | 15.38 | |
| Hca Holdings (HCA) | 1.0 | $3.4M | 60k | 56.38 | |
| Nektar Therapeutics (NKTR) | 1.0 | $3.3M | 260k | 12.82 | |
| Celldex Therapeutics | 1.0 | $3.2M | 199k | 16.32 | |
| Endologix | 0.9 | $3.1M | 205k | 15.21 | |
| Myriad Genetics (MYGN) | 0.9 | $3.1M | 80k | 38.92 | |
| Catamaran | 0.9 | $3.1M | 70k | 44.16 | |
| Edwards Lifesciences (EW) | 0.9 | $3.0M | 35k | 85.83 | |
| WellPoint | 0.9 | $3.0M | 28k | 107.61 | |
| PAREXEL International Corporation | 0.9 | $2.9M | 55k | 52.84 | |
| Universal Health Services (UHS) | 0.8 | $2.9M | 30k | 95.77 | |
| Varian Medical Systems | 0.8 | $2.8M | 34k | 83.15 | |
| Revance Therapeutics (RVNC) | 0.8 | $2.8M | 82k | 34.00 | |
| Eli Lilly & Co. (LLY) | 0.8 | $2.8M | 45k | 62.18 | |
| St. Jude Medical | 0.8 | $2.8M | 40k | 69.25 | |
| Abiomed | 0.8 | $2.7M | 107k | 25.14 | |
| NuVasive | 0.8 | $2.7M | 76k | 35.57 | |
| Centene Corporation (CNC) | 0.8 | $2.6M | 35k | 75.60 | |
| UnitedHealth (UNH) | 0.8 | $2.6M | 32k | 81.75 | |
| Ligand Pharmaceuticals In (LGND) | 0.8 | $2.6M | 42k | 62.29 | |
| Ariad Pharmaceuticals | 0.7 | $2.5M | 390k | 6.37 | |
| Achillion Pharmaceuticals | 0.7 | $2.5M | 330k | 7.57 | |
| Supernus Pharmaceuticals (SUPN) | 0.7 | $2.5M | 227k | 10.95 | |
| Thoratec Corporation | 0.7 | $2.4M | 68k | 34.86 | |
| Zimmer Holdings (ZBH) | 0.7 | $2.3M | 23k | 103.87 | |
| Idenix Pharmaceuticals | 0.7 | $2.3M | 97k | 24.10 | |
| AFLAC Incorporated (AFL) | 0.7 | $2.2M | 36k | 62.25 | |
| CareFusion Corporation | 0.7 | $2.2M | 50k | 44.36 | |
| NPS Pharmaceuticals | 0.7 | $2.2M | 67k | 33.04 | |
| C.R. Bard | 0.6 | $2.1M | 15k | 143.00 | |
| AmerisourceBergen (COR) | 0.6 | $2.1M | 29k | 72.67 | |
| Masimo Corporation (MASI) | 0.6 | $2.1M | 87k | 23.60 | |
| Dynavax Technologies Corporation | 0.6 | $2.0M | 1.2M | 1.60 | |
| Omnicare | 0.6 | $1.9M | 29k | 66.56 | |
| Orexigen Therapeutics | 0.6 | $1.9M | 300k | 6.18 | |
| Hologic (HOLX) | 0.6 | $1.9M | 73k | 25.36 | |
| Rite Aid Corporation | 0.6 | $1.9M | 260k | 7.17 | |
| Hyperion Therapeutics | 0.6 | $1.8M | 70k | 26.11 | |
| Cerner Corporation | 0.5 | $1.8M | 35k | 51.57 | |
| Amgen (AMGN) | 0.5 | $1.8M | 15k | 118.40 | |
| Mednax (MD) | 0.5 | $1.7M | 30k | 58.17 | |
| Tesaro | 0.5 | $1.7M | 55k | 31.11 | |
| Cepheid | 0.5 | $1.7M | 35k | 47.94 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $1.7M | 98k | 16.86 | |
| Array BioPharma | 0.5 | $1.5M | 329k | 4.56 | |
| Infinity Pharmaceuticals (INFIQ) | 0.4 | $1.4M | 113k | 12.74 | |
| Bind Therapeutics | 0.4 | $1.4M | 109k | 13.18 | |
| Aegerion Pharmaceuticals | 0.4 | $1.3M | 42k | 32.10 | |
| Teva Pharmaceutical Industries (TEVA) | 0.4 | $1.3M | 25k | 52.44 | |
| Sunesis Pharmaceuticals | 0.4 | $1.3M | 201k | 6.52 | |
| Macrogenics (MGNX) | 0.4 | $1.3M | 60k | 21.73 | |
| Stryker Corporation (SYK) | 0.4 | $1.3M | 15k | 84.33 | |
| AmSurg | 0.4 | $1.2M | 27k | 45.57 | |
| ISIS Pharmaceuticals | 0.4 | $1.2M | 36k | 34.44 | |
| Aetna | 0.4 | $1.2M | 15k | 81.07 | |
| ImmunoGen | 0.3 | $1.2M | 99k | 11.85 | |
| Intuitive Surgical (ISRG) | 0.3 | $1.0M | 2.5k | 412.00 | |
| Exelixis (EXEL) | 0.3 | $1.0M | 300k | 3.39 | |
| Anthera Pharmaceutcls | 0.3 | $1.0M | 300k | 3.39 | |
| Volcano Corporation | 0.2 | $779k | 44k | 17.62 | |
| Celladon | 0.2 | $737k | 46k | 16.02 | |
| Express Scripts Holding | 0.2 | $693k | 10k | 69.30 | |
| Sorrento Therapeutics (SRNEQ) | 0.1 | $490k | 73k | 6.76 | |
| Lexicon Pharmaceuticals | 0.1 | $475k | 295k | 1.61 | |
| Threshold Pharmaceuticals | 0.1 | $481k | 122k | 3.96 | |
| Haemonetics Corporation (HAE) | 0.1 | $354k | 10k | 35.23 | |
| Endocyte | 0.1 | $325k | 49k | 6.59 |
